🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative discoveries that clarify how the body's defense network targets harmful infections while sparing the body's own cells.

Three esteemed scientists—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this accolade.

The work identified specialized "sentinels" within the immune system that remove rogue immune cells capable of harming the organism.

The findings are now paving the way for innovative treatments for immune disorders and malignancies.

These winners will share a prize fund valued at 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for understanding how the immune system functions and why we don't all develop severe self-attack conditions," stated the head of the Nobel Committee.

This team's research explain a core question: In what way does the immune system protect us from numerous invaders while leaving our healthy cells unharmed?

Our immune system uses white blood cells that scan for indicators of infection, including pathogens and germs it has never encountered.

These cells employ sensors—known as recognition units—that are produced randomly in a vast number of combinations.

That gives the defense network the ability to combat a wide array of threats, but the randomness of the process unavoidably produces immune cells that may target the body.

Security Guards of the Immune System

Researchers earlier knew that some of these problematic white blood cells were eliminated in the thymus—the site where immune cells develop.

The latest Nobel Prize honors the discovery of T-reg cells—known as the immune system's "security guards"—which patrol the body to disarm any defenders that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "These discoveries have laid the foundation for a new field of research and accelerated the development of new therapies, for instance for tumors and immune disorders."

Regarding malignancies, T-regs prevent the body from fighting the tumor, so studies are focused on reducing their quantity.

For self-attack disorders, trials are testing increasing regulatory T-cells so the body is not being harmed. A comparable approach could also be effective in minimizing the risks of transplanted organ rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.

The researcher showed that introducing immune cells from other mice could stop the illness—suggesting there was a system for preventing immune cells from harming the body.

Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in rodents and people that resulted in the identification of a gene vital for how regulatory T-cells function.

"The pioneering research has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," commented a leading biological science expert.

"The work is a striking example of how fundamental biological research can have broad consequences for public health."